Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

RECeSS

Financiado

Robust Explainable Controllable Standard for drug Screening

In 2021, drug development pipelines last 10 years in average, and cost around $2 billion, while facing high failure rates, as only around 10% of Phase 0 drug candidates reach the commercialization stage. These issues can be mitiga... ver más

30/04/2025

UROS

190K€

Presupuesto del proyecto: 190K€

Líder del proyecto

UNIVERSITAET ROSTOCK No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 2 Participantes

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2023-03-07

HORIZON-MSCA-2022-PF-01-01: MSCA Postdoctoral Fellowships 2022 ExpectedOutcome:

I+D

Cerrada hace 2 años

0% 100% 100%

2 Participantes

UROS

189.69K€ | Lider

INRIA

N.D. | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

PRE2021-100416 MEDICINA INTERCEPTIVA, DESCUBRIMIENTO DE DIANAS Y REUTILIZAC... 101K€ Cerrado

TIN2012-31377 ADQUISICION DE CONOCIMIENTO EN FARMACOPROTEOMICA MEDIANTE ME... 39K€ Cerrado

GenDrug Genetically anchored drug target discovery for neglected dis... 1M€ Cerrado

PRE2018-085169 APLICACION DE METODOS DE APRENDIZAJE AUTOMATICO Y DE AUMENTO... 93K€ Cerrado

UNAB13-4E-1659 Sistema de cálculo intensivo y almacenamiento en red de alta... 82K€ Cerrado

mCUBE Multi-omic data driven drug discovery and indication priorit... 4M€ Cerrado

Duración del proyecto: 25 meses Fecha Inicio: 2023-03-07
Fecha Fin: 2025-04-30

Líder del proyecto

UNIVERSITAET ROSTOCK No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 190K€

Descripción del proyecto In 2021, drug development pipelines last 10 years in average, and cost around $2 billion, while facing high failure rates, as only around 10% of Phase 0 drug candidates reach the commercialization stage. These issues can be mitigated through drug repurposing, where existent compounds are systematically screened for new therapeutic indications. Collaborative filtering is a semi-supervised learning framework that leverages known drug-disease matchings to make novel recommendations. However, prior works cannot be leveraged because of their lack of focus on human oversight and robustness to biological data. This project aims at bridging the gap between drug research and collaborative filtering by implementing a RECeSS classifier, that is (1) Robust: deals with class imbalance in drug-disease matchings, and missing drug/disease features, by semi-supervised learning; (2) Explainable: connects predicted matchings to perturbed biological pathways through enrichment analyses, based on the learnt importance of features in the model; (3) Controllable: guarantees a bound on the false positive rate using an adaptive learning scheme; (4) Standard: algorithms are trained and tested by a standardized open-source pipeline. Predicted matchings will be independently validated by structure-based methods. This innovative interdisciplinary project relies on a solid basis of newly curated data (up to 1,386 drugs, 1,599 diseases, 12 feature types). It is primarily supervised by Pr. Olaf Wolkenhauer, at SBI Rostock, whose team has an expertise in drug repurposing, in systems biology and data imbalance in machine learning. This project will help the fellow develop new skills, and enhance her professional maturity in academia. In the short term, this would yield the first method that fully integrates biological interpretation and risk assessment to collaborative filtering-based repurposing. Long-term outcomes might help define sustainable and transparent drug development for rare diseases.

Conecta tu I+D

Entra hoy

¿Olvidó su contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores